Matthew “Tex” VerMilyea, PhD, HCLD/CC, Vice President of Scientific Advancement, Ovation Fertility “One of the most powerful contributors to Ovation’s success is our collaborative approach to research ...
SARASOTA, Fla. and ANAHEIM, Calif., Oct. 17, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System ...
PARSIPPANY, N.J., Oct. 19, 2022 /PRNewswire/ -- Ferring Pharmaceuticals today announced that it will presenting a company-sponsored abstract highlighting an in-depth analysis of future trends in the ...
North America's largest fertility provider to present new abstracts, lead roundtable discussions that focus on mental health and infertility and offer postgraduate courses HOUSTON, Oct. 24, 2022 ...
BOONTON, N.J., July 14, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned ...
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to ...
- The multi-billion-dollar global fertility market is predicted to reach approximately US$47.9 billion by 2030, yet remains severely underserved with many patients (upwards of 90% by many estimates) ...
North America's largest fertility provider to present new abstracts, lead roundtable discussions that focus on mental health and infertility and offer postgraduate courses ASRM is a professional ...
Nashville, Oct. 25, 2022 (GLOBE NEWSWIRE) -- teams are presenting six poster presentations at the 2022 ASRM Scientific congress & Expo, which takes place in Anaheim, California, October 22-26, 2022.
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results